Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Piper Sandler, Abbott Laboratories
Piper Sandler initiates Abbott Laboratories with "overweight" rating, $131 PT
Piper Sandler initiated coverage on Abbott Laboratories (NYSE:ABT) with an "overweight" rating and a price target of $131 per share. Piper Sandler emphasizes Abbott’s attractive valuation, strong financial outlook,
Piper Sandler Initiates Coverage of Abbott Laboratories (ABT) with Overweight Recommendation
Fintel reports that on September 19, 2024, Piper Sandler initiated coverage of Abbott Laboratories (NYSE:ABT) with a Overweight recommendation. Analyst Price Forecast Suggests 10.13% Upside As of August 26,
Piper Sandler Initiates Coverage of Abbott Laboratories (LSE:0Q15) with Overweight Recommendation
Fintel reports that on September 19, 2024, Piper Sandler initiated coverage of Abbott Laboratories ( LSE:0Q15) with a Overweight recommendation. What is the Fund Sentiment?
2d
Abbott Laboratories stock outperforms competitors despite losses on the day
This was the stock's third consecutive day of losses.
7d
Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy?
Let's not forget about Abbott Laboratories' impressive streak of 52 consecutive annual dividend increases, which also makes ...
Law
4d
Who Got the Work: O'Melveny Set to Defend Abbott Labs in Digital Privacy Class Action
O'Melveny & Myers is defending
Abbott
Laboratories
in a pending class action against the company and two other ...
3d
Abbott Laboratories' Attractive Valuation Ranks It Among Top Large-Cap MedTech Companies, Says Analyst
Piper Sandler initiates coverage on Abbott with an Overweight rating, citing its diversified business model, strong medtech ...
12d
Abbott Laboratories: Cardiovascular Disease Has Been A Tailwind, But Things Could Change
Cardiovascular disease is rising, and Abbott Laboratories is well-positioned in the CVD treatment space. Read why I'm neutral ...
6d
Abbott Laboratories stock outperforms competitors on strong trading day
Abbott Laboratories closed $4.01 short of its 52-week high ($121.64), which the company reached on March 8th.
4d
Buy Rating on Abbott Laboratories: Undervalued with Strong Growth Prospects Despite NEC Litigation
Adam Maeder, an analyst from Piper Sandler, has initiated a new Buy rating on Abbott Laboratories (ABT). Adam Maeder has given his Buy rating ...
4h
Abbott Drive cut to one lane near Omaha's Eppley airport — again
Abbott Drive can’t seem to get enough of the orange construction cones. For the second time this year, the Omaha Airport ...
Hoodline
1h
Marine Veteran Honored with Custom Built Home in New Braunfels by Governor Abbott and HFOT
Governor Abbott presented Marine Lance Corporal Flores with a custom-built home by HFOT, the nonprofit's 400th, honoring his ...
Zacks.com on MSN
4d
Abbott Stock Hurt by Macroeconomic Issues & FX Headwind
Foreign exchange fluctuation is a major headwind for ABT, as a considerable percentage of its revenues comes from outside the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Tren de Aragua
Venezuelan gang
Piper Sandler
FreeStyle Libre
Governor of Texas
Feedback